QSAM Biosciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Debentures, Convertible Bridge Notes, and Notes Payable (Details Narrative)

Debentures, Convertible Bridge Notes, and Notes Payable (Details Narrative) - USD ($)				1 Months Ended	2 Months Ended		3 Months Ended				9 Months Ended		12 Months Ended
	Sep. 30, 2020	Apr. 14, 2020	Apr. 07, 2020	Jun. 30, 2018	Nov. 30, 2020	Oct. 31, 2020	Dec. 31, 2020	Sep. 30, 2020	Sep. 09, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Procceds from convertible debt											$ 142,500	$ 30,000
Accrued interest	$ 57,821							$ 57,821			57,821		$ 15,426
Loss on extinguishment of debt								(503,762)			(503,762)
Change in fair value of convertible bridge notes								(1,343,237)		$ 735,805	(1,666,422)	490,079
Note payable	1,078,873							1,078,873			1,078,873		788,500
Proceeds from related party debt											335,873	425,000
Paycheck Protection Program [Member]
Debt instrument, interest rate		1.00%
Proceeds from loans		$ 142,942
Debt instrument maturity date		Apr. 14, 2022
Note payable	142,929							142,929			$ 142,929
Subsequent Event [Member]
Equity offering cost							$ 3,000,000
Common Stock [Member]
Debt conversion into shares											11,418,069
Three Directors [Member]
Debt instrument maturity date			Jun. 30, 2020
Proceeds from related party debt			$ 15,000
Senior Secured Convertible Debentures [Member]
Convertible promissory note	$ 165,000							$ 165,000			$ 165,000		$ 165,000
Conversion price per share	$ 2.50							$ 2.50			$ 2.50		$ 2.50
Bridge Offering [Member] \| In 2017 and 2018 [Member]
Procceds from convertible debt											$ 2,771,908
Bridge Offering [Member] \| In 2017 and 2018 [Member] \| Three Directors [Member]
Debt conversion, value											156,368
Bridge Offering [Member] \| In 2017 and 2018 [Member] \| One Shareholder [Member]
Debt conversion, value											11,784
Follow-On Bridge Offering [Member]
Debt conversion, value				$ 50,000
Accrued interest				$ 7,664
Debt conversion into shares				24,538
Annual interest rate, description				One of the original Bridge Notes for $50,000 plus $7,664 accrued interest was converted by its holder into 24,538613,451 shares of common stock. Maturity is 36 months from issuance (24 months for the Bridge Notes issued in 2018 and 2019) with 15% annual interest which is capitalized each year into the principal of the Bridge Notes and paid in kind.
Follow-On Bridge Offering [Member] \| Investors [Member]
Bridge offering amount													$ 30,000
Bridge Notes [Member]
Convertible promissory note	$ 1,646,646							$ 1,646,646			$ 1,646,646
Debt, term											36 months
Repayments of notes payable	2,511,975
Debt principal and accrued capitalized interest	$ 1,777,516							$ 1,777,516			$ 1,777,516
Debt instrument, interest rate	15.00%							15.00%			15.00%
Bridge Notes [Member] \| Subsequent Event [Member]
Conversion price per share						$ 0.22
Debt conversion amount						$ 130,000
Debt principal and accrued capitalized interest					$ 130,000
Bridge Notes [Member] \| Common Stock [Member]
Debt conversion into shares											11,418,069
Debt conversion amount											$ 2,397,794
Bridge Notes [Member] \| Common Stock [Member] \| Subsequent Event [Member]
Debt conversion into shares					590,909
2018 and 2019 Bridge Notes [Member]
Debt, term											24 months
Convertible Promissory Notes [Member]
Debt, term											36 months
Change in fair value of convertible bridge notes											$ 1,666,422	$ 490,079
Convertible bridge notes, principal amount due											1,903,415		2,801,908
Fair value of convertible bridge notes	$ 2,981,000							$ 2,981,000			$ 2,981,000		$ 2,473,000
Debt instrument, interest rate	15.00%							15.00%			15.00%
Promissory Note [Member] \| Unrelated Third Party [Member]
Convertible promissory note	$ 142,500							$ 142,500			$ 142,500
Debt instrument, interest rate									8.00%
Proceeds from related party debt									$ 142,500
Equity offering cost									$ 1,000,000